The mechanisms that drive the diverse disease manifestations and increased cancer risk associated with systemic sclerosis are unclear. Investigating the genomic alterations observed in patients ...

Nearly 40% of pregnancy-capable patients with rheumatic disease are unaware of the potential impacts of their medications on ...

Rheumatic heart disease is a chronic condition that results years after acute rheumatic fever, which is caused by group A beta-hemolytic Streptococcus pyogenes. This organism produces a ...

Lupus can do irreversible harm to a person's organs, damaging the lungs, kidneys, heart, liver and other vital organs through ...

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new sophistication. The management of chronic pain in general is now being broadly ...

Children with rheumatic diseases face increased risks for COVID-19-related hospitalization, though the use of tumor necrosis factor-alpha inhibitors may offer protective benefits. Children with ...

A RECENT review of the literature 1 and our own experience at the House of the Good Samaritan 2–5 suggest that early treatment of rheumatic fever with ACTH and cortisone may prevent or mitigate ...

The research of the Helsinki Rheumatic diseases and Inflammation Group focuses on studying the mechanisms of inflammation in rheumatic diseases and osteoarthritis, with special emphasis on role of ...

Funding streams for both chronic and acute medical conditions are, and have always been, a critically conjoined public health need. A century ago, in the pre-antibiotic era, rheumatic fever was a ...

Low-dose methotrexate was not clinically effective for lowering blood pressure among patients without rheumatic disease who have cardiovascular risk factors.